1
EXHIBIT 10.12
AMENDMENT NO. 2 TO LICENSING AGREEMENT
This Amendment No 2 to licensing Agreement (this "Amendment"), dated as of July
31, 1998 is entered into by and between the Xxxx-Xxxxxx Cancer Institute, Inc.,
a Massachusetts non-profit corporation ("DFCI"), and Corixa Corporation, a
Delaware corporation ("Corixa").
RECITALS
A. DFCI and Corixa are parties to that certain Licensing Agreement, dated as
of January 1, 1995 (the "License Agreement"), as amended on September 15,
1997, pursuant to which DFCI has granted to Corixa certain rights under
the Patent Rights and Technical Information as defined therein.
B. DFCI and Corixa desire to amend the License Agreement as set forth below.
NOW THEREFORE, the parties hereto agree to amend the License Agreement as
follows:
AMENDMENT
1. DEFINITIONS
Except as otherwise defined herein, capitalized terms used in this Amendment
shall have the meanings designated in the License Agreement.
2. DUE DILIGENCE
The last line of Section 3.1 shall be deleted and replaced with the
following:
File IND By 12/98
3. FULL FORCE AND EFFECT
Except as amended hereby, the License Agreement shall remain in full force and
effect in accordance with its terms.
IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly
executed as of the date first above written.
XXXX-XXXXXX CANCER INSTITUTE, INC. CORIXA CORPORATION
By: /s/ XXXX EMYANIZOFF, PH.D. /s/ XXXX XXXXXX
-------------------------------- -------------------------------------
Xxxx Emyanizoff, Ph.D. Xxxx XxXxxx
Director, Office of Technology Chief Operating Officer
Transfer
1
